Drug Trial Radar · NCT04149210
FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial
Last checked: Nov 19, 2026Latest source record: Mar 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,410
Actual
Start
Aug 19, 2021
Primary completion
Nov 30, 2024
Study completion Nov 30, 2024
Sponsor
- Lead sponsor
- Massachusetts Eye and Ear InfirmaryAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Pennsylvania; London School of Hygiene and Tropical Medicine; Berhan Public Health and Eye Care Consultancy PLC; The Fred Hollows Foundation, Ethiopia; The Fred Hollows Foundation, Australia
- First posted
- Nov 4, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 15 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims : * To assess the efficacy of fluorometholone 0.1% one drop twice daily for four weeks in reducing the incidence of post-operative trachomatous trichiasis (TT) when given as adjunctive therapy with TT surgery in the programmatic setting * To assess whether such treatment is sufficiently safe for wide-scale implementation in TT programs. * To estimate the costs of adding fluorometholone 0.1% treatment to TT surgery per case of postoperative TT averted, and to characterize the value of such treatment under a range of plausible health economic circumstances
Conditions
- Trachomatous Trichiasis (TT)
- Eye Diseases
- Eyelid Diseases
- Trachomatous
- Trichiasis
Interventions
Fluorometholone 0.1% Oph SuspDrug
fluorometholone 0.1% one drop twice daily for four weeks, beginning with one drop just before trachomatous trichiasis surgery on the upper lid.
Artificial TearsDrug
Artificial tears (placebo) given one drop twice daily for four weeks, beginning with one drop just prior to trachomatous trichiasis surgery on the upper lid.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Postoperative TT by One Year, as Determined by Trained Study Team MembersTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Oromia Health Bureau
Addis Ababa, Addis Ababa, Ethiopia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.